RxDoctor Payments Data

Mitchell Paulin, MD

Physical Medicine & Rehabilitation · Paoli, PANPI 1306930243

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $168,614 of the $229,296 with a category attached, or 73.5%. 10 manufacturers reported payments, led by AbbVie at 48.1% of the total. Reporting peaked in 2023 at $59,941 and has fallen 86.1% since, to $8,310 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$229,296in general payments, 2019–2025

Across 280 payments — averaging $818.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$110K
  • Ipsen Biopharmaceuticals, Inc$100K
  • Merz Pharmaceuticals, LLC$16K
  • Medtronic$2K
  • Ipsen Pharma SAS$479
  • Revance Therapeutics, Inc.$248
  • plus $236 from 4 others

What the payments were for

  • Consulting fees$28,94613%
  • Speaking & faculty fees$168,61474%
  • Travel & lodging$24,41011%
  • Food & beverage$7,3263%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)147$110,257
Ipsen Biopharmaceuticals, Inc94$99,842
Merz Pharmaceuticals, LLC10$16,291
Medtronic(2 entities)15$1,944
Ipsen Pharma SAS2$479
Revance Therapeutics, Inc.7$248
Piramal Critical Care1$102
Merz North America, Inc.1$88
Neurocrine Biosciences, Inc.2$35
MDD US Operations, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$229,296 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,215,417
Medicare patients
204
Services billed
125,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DysportAbobotulinumtoxina62$126,105
BotoxOnabotulinumtoxina23$38,075
Baclofen35$1,246
Tizanidine Hcl31$145
Diazepam15$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ipsen Biopharmaceuticals, IncDysport$99,842$126,10562 claims
AbbVieBotox$110,257$38,07523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

Other physical medicine & rehabilitation in Paoli

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →